These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 6820905)

  • 1. Metabolism of 1,3-bis(tetrahydro-2-furanyl)-5-fluorouracil in mice.
    Fujimoto S; Ishigami H; Minami T; Miyazaki M; Itoh K; Kimura K
    J Natl Cancer Inst; 1979 Aug; 63(2):465-8. PubMed ID: 379401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of UFT administered preoperatively in cases of gastric cancer (author's transl)].
    Okada K; Kitade F; Kawashima Y; Yamada S; Sakuramoto K; Kanbara H; Okajima K; Kurokawa A
    Nihon Gan Chiryo Gakkai Shi; 1981 Dec; 16(7):1417-22. PubMed ID: 6804580
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase I and pharmacokinetic study of oral UFT, a combination of the 5-fluorouracil prodrug tegafur and uracil.
    Muggia FM; Wu X; Spicer D; Groshen S; Jeffers S; Leichman CG; Leichman L; Chan KK
    Clin Cancer Res; 1996 Sep; 2(9):1461-7. PubMed ID: 9816321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical experiences with UFD-1].
    Furue H
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):672-4. PubMed ID: 6820905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
    Hoff PM; Pazdur R; Benner SE; Canetta R
    Anticancer Drugs; 1998 Jul; 9(6):479-90. PubMed ID: 9877235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Invention of a tumor-selective 5-fluorouracil derivative named S-1 by biochemical modulation of 5-fluorouracil].
    Shirasaka T; Shimamoto Y; Kato T; Fukushima M
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):371-84. PubMed ID: 9492831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New oral anticancer drug, TS-1 (S-1)--from bench to clinic].
    Shirasaka T; Tsukuda M; Inuyama Y; Taguchi T
    Gan To Kagaku Ryoho; 2001 Jun; 28(6):855-64. PubMed ID: 11432358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UFT: biochemical modulation for 5-fluorouracil (5-FU).
    Taguchi T
    Chin Med J (Engl); 1997 Apr; 110(4):294-6. PubMed ID: 9594232
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical use of platinum compounds and fluorinated pyrimidines for lung cancer].
    Kobayashi K
    Gan To Kagaku Ryoho; 1996 Nov; 23(13):1747-56. PubMed ID: 8937484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics of S-1].
    Hirata K; Horikoshi N; Tominaga K; Sohma K; Yamaguchi K; Okazaki M; Furuhata T; Sasaki K; Nakano Y; Ishizuka H; Yamada Y; Uno S; Taguchi T; Yamamitsu S; Shirasaka T
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():27-35. PubMed ID: 16897969
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.